---
schema_version: "secwatch.filing_event.v1"
accession: "0001599298-26-000049"
form_type: "8-K"
ticker: "SMMT"
cik: "0001599298"
company_name: "Summit Therapeutics Inc."
filed_at: "2026-06-03T12:01:16+00:00"
generated_at: "2026-06-03T12:05:22.782097+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Summit Therapeutics authorizes affiliates and executives to purchase shares under ATM offering

## Summary
- Audit Committee and independent directors approved company affiliates to buy shares under existing ATM with JP Morgan.
- Co-CEOs Robert Duggan and Mahkam Zanganeh and COO/CFO Manmeet Soni indicated likely personal purchases in near term.
- No specific share numbers or formal binding commitments disclosed; purchases at prevailing bid or better.

## SEC filing metadata
- accession: 0001599298-26-000049
- form_type: 8-K
- ticker: SMMT
- cik: 0001599298
- company_name: Summit Therapeutics Inc.
- filed_at: 2026-06-03T12:01:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1599298/000159929826000049/0001599298-26-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1599298/000159929826000049/smmt-20260602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001599298-26-000049
- JSON: https://secwatch.observer/filing/0001599298-26-000049.json
- Plain text: https://secwatch.observer/filing/0001599298-26-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.